Financial Survey: Mitesco (OTCMKTS:MITI) versus HeartSciences (NASDAQ:HSCS)

Mitesco (OTCMKTS:MITI) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

Earnings and Valuation

This table compares Mitesco and HeartSciences”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mitesco	$40,000.00	47.83	$500,000.00	($0.36)	-0.26
HeartSciences	N/A	N/A	-$8.77 million	($4.94)	-0.41

Mitesco has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Mitesco and HeartSciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mitesco	0	0	0	0	0.00
HeartSciences	1	0	1	0	2.00

HeartSciences has a consensus target price of $8.00, indicating a potential upside of 292.16%. Given HeartSciences’ stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Mitesco.

Institutional & Insider Ownership

0.0% of Mitesco shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 4.9% of Mitesco shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Profitability

This table compares Mitesco and HeartSciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Mitesco	-7,638.20%	-2.18%	303.55%
HeartSciences	N/A	-333.50%	-140.18%

Volatility and Risk

Mitesco has a beta of 5.6, suggesting that its stock price is 460% more volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.44, suggesting that its stock price is 144% more volatile than the S&P 500.

Summary

Mitesco beats HeartSciences on 7 of the 12 factors compared between the two stocks.

About Mitesco

Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.

About HeartSciences

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.